AVITA Medical Inc（RCEL）价格预测

$10.940

+0.183 (+1.67%)收盘时

价格预测

1-Day Price Prediction

-1.28%

1-Week Prediction

-2.71%

1-Month Prediction

—

2026 Prediction

—

2030 Prediction

—

在 App 中打开以解锁更长周期的预测。

Loading chart…

RCEL 相似图表分析预测

Alphio's RCEL stock price prediction model matches the current AVITA Medical Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $10.80 (-1.28%). The 1-week path is $10.64 (-2.71%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.

该买入 AVITA Medical Inc 股票吗？

AVITA Medical Inc (RCEL) is a good buy right now, trading at $10.35 with a strong recent performance of 198.27% year-to-date. The RSI is at 73.4, indicating strong momentum, and analysts have raised their price targets to a range of $11 to $14, suggesting significant upside potential. The main risk is the company's ongoing net losses, which were $7.66 million in Q2 2026, but the trend shows improvement in revenue and cost management.

RCEL 股价于 Thursday 收于 $10.94，此前上涨 +1.67%

AVITA Medical Inc (RCEL) last closed at $10.94, gaining +1.67%. These facts feed the 1-day and 1-week RCEL price prediction above.

预测驱动因素

AVITA Medical Inc（RCEL）的预测驱动因素综合了相似的图表形态、季节性与移动平均线。

Similar patterns

Positive

Bullish

Seasonality

Negative

Bearish

SMA 20

Positive

Bullish

SMA 200

Positive

Bullish

相似图表形态

近期走势与 RCEL 最接近的股票，按相似度排序。

USB

94.52%

+2.28%

FITB

94.19%

+3.91%

93.69%

-7.46%

SSL

93.54%

-17.13%

CCI

93.31%

+1.10%

RCEL 季节性分析

Historically the probability of a positive September return for RCEL is 6.82%. February offers the highest probability of a positive month at 67.24%, while October is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.

Loading chart…